BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17806107)

  • 1. Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent.
    Erdogan D; van Gulik TM
    J Biomed Mater Res B Appl Biomater; 2008 Apr; 85(1):272-8. PubMed ID: 17806107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemostatic effect of a novel sheeted fibrin adhesive agent, TO-193, on experimental incision models].
    Ueda N; Maekawa Y; Ohtani H; Uchiyama H; Kashiwabara S; Koshiyama Y; Oda M; Kurumi M
    Nihon Yakurigaku Zasshi; 1999 Mar; 113(3):177-84. PubMed ID: 10347842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in Swine.
    Pusateri AE; Modrow HE; Harris RA; Holcomb JB; Hess JR; Mosebar RH; Reid TJ; Nelson JH; Goodwin CW; Fitzpatrick GM; McManus AT; Zolock DT; Sondeen JL; Cornum RL; Martinez RS
    J Trauma; 2003 Sep; 55(3):518-26. PubMed ID: 14501897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a fibrinogen-thrombin-collagen-based hemostyptic agent in experimental injuries of liver and spleen.
    Schelling G; Block T; Gokel M; Blanke E; Hammer C; Brendel W
    J Trauma; 1988 Apr; 28(4):472-5. PubMed ID: 2451032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model.
    Matonick JP; Hammond J
    J Invest Surg; 2014 Dec; 27(6):360-5. PubMed ID: 25361019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of a fibrinogen-thrombin-collagen-based hemostatic agent in an experimental arterial bleeding model.
    Schelling G; Block T; Blanke E; Hammer C; Brendel W; Gokel M
    Ann Surg; 1987 Apr; 205(4):432-5. PubMed ID: 2436584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen-fibrin conversion and inhibition of fibrinolysis.
    Stemberger A; Blümel G
    Thorac Cardiovasc Surg; 1982 Aug; 30(4):209-14. PubMed ID: 6182629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with a multi-component fleece (MCF) in patients with hemorrhagic tendencies].
    Beckers H; Brakonier F
    Dtsch Zahnarztl Z; 1986 May; 41(5):515-8. PubMed ID: 2427309
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage.
    Schwaitzberg SD; Chan MW; Cole DJ; Read M; Nichols T; Bellinger D; Connolly RJ
    J Trauma; 2004 Jul; 57(1 Suppl):S29-32. PubMed ID: 15280748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a novel hemostatic device in an ovine parenchymal organ bleeding model of normal and impaired hemostasis.
    Turner AS; Parker D; Egbert B; Maroney M; Armstrong R; Powers N
    J Biomed Mater Res; 2002; 63(1):37-47. PubMed ID: 11787027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Coagulant Agents.
    Sheppard OO; Foje NA
    Surg Clin North Am; 2022 Feb; 102(1):65-83. PubMed ID: 34800390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of sheet-type absorbable topical collagen hemostat used to prevent pulmonary fistula after lung surgery.
    Miyamoto H; Sakao Y; Sakuraba M; Oh S; Takahashi N; Miyasaka Y; Akaboshi T; Inagaki T
    Ann Thorac Cardiovasc Surg; 2010 Aug; 16(1):16-20. PubMed ID: 20190704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of microcrystalline collagen powder and fibrinogen tissue adhesive for hemostasis and prevention of rebleeding in patients with hepatocellular carcinoma associated with cirrhosis of the liver.
    Sakon M; Monden M; Gotoh M; Kobayashi K; Kambayashi J; Mori T; Okamura J
    Surg Gynecol Obstet; 1989 May; 168(5):453-4. PubMed ID: 2469132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of hemostatic agents and sealants in urology.
    Hong YM; Loughlin KR
    J Urol; 2006 Dec; 176(6 Pt 1):2367-74. PubMed ID: 17085103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results with collagen fleece coated with fibrin glue (TachoComb). A macroscopical and histological experimental study.
    Martis G; Mikó I; Szendröi T; Kathy S; Kovács J; Hajdu Z
    Acta Chir Hung; 1997; 36(1-4):221-2. PubMed ID: 9408353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined application of heterologous collagen and fibrin sealant for liver injuries.
    Jakob H; Campbell CD; Stemberger A; Wriedt-Lübbe I; Blümel G; Replogle RL
    J Surg Res; 1984 Jun; 36(6):571-7. PubMed ID: 6374292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic therapy of upper gastrointestinal bleeding in humans.
    Fleischer D
    Gastroenterology; 1986 Jan; 90(1):217-34. PubMed ID: 3079596
    [No Abstract]   [Full Text] [Related]  

  • 19. Sealing of gastrointestinal anastomoses with fibrin glue coated collagen patch.
    Nordentoft T
    Dan Med J; 2015 May; 62(5):. PubMed ID: 26050838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent Hemostatic Efficacy of a Novel Recombinant Fibrin Sealant Patch (KTF-374) in Rabbit Bleeding Models.
    Miyabashira Tanaka S; Imamura T; Fujimoto M; Ohno A; Kobayashi T; Shinya N
    J Invest Surg; 2019 Apr; 32(3):257-261. PubMed ID: 29260920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.